Rahel Horisberger

Rahel Horisberger

Auto-generated profile, based on publicly available information

Rahel Horisberger

Department of Adult Psychiatry and Psychotherapy, Psychiatric Hospital, University of Zurich, Zurich, Switzerland

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2025 in Schizophrenia
Verified
Journal Article
Open access
PDF file
Pierfrancesco SartiPierfrancesco Sarti
Pierfrancesco Sarti
WSWerner Surbeck
Werner Surbeck
GCGiacomo Cecere
Giacomo Cecere
NDNoemi Dannecker
Noemi Dannecker
RHRahel Horisberger
Rahel Horisberger
PHPhilipp Homan
Philipp Homan
Schizophrenia spectrum disorders and schizotypy share traits across positive, negative, and disorganised domains. Instruments like the Multidimensional Schizotypy Scale (MSS) and the Oxford-Liverpool Inventory (O-LIFE) offer nuanced perspectives on schizotypy, including its expression as a personality trait and its potential clinical outcomes. This study investigates the structure of schizotypy using exploratory graph analysis (EGA) to analyse how the MSS and O-LIFE operationalise the construct in the same sample of German speakers. This approach allows comparison of their factorial structures from both statistical and clinical perspectives, while also assessing cross-cultural validity. 1059 German-speaking, healthy participants completed the MSS and O-LIFE questionnaires. EGA was conducted to identify dimensional structures within each scale, utilising the graphical lasso algorithm for network estimation and the Walktrap community detection method for clustering. Confirmatory factor analysis was used to assess model fit and reliability, using indices such as the comparative fit index and root mean square error of approximation. EGA of the MSS revealed three primary dimensions and an additional ‘dissociated’ domain. This four-dimensional model showed improved fit and reliability compared to the original model. For the O-LIFE, EGA identified a refined four-factor structure comprising: 'cognitive and behavioural disorganisation,’ ‘introversion’, ‘unusual experiences’, and ‘environmental valence’, all validated by confirmatory analyses. This study supports the multidimensional view of schizotypy, introducing new factor structures in the MSS and O-LIFE that emphasise the previously unexplored domains ‘dissociated’ and ‘environmental valence.’ These findings highlight the value of culturally adaptive tools in enhancing schizotypy assessment and intervention strategies.

28 January 2025 in Schizophrenia Bulletin Open
Verified
Journal Article
Open access
JPJanani Panchalingam
Janani Panchalingam
RHRahel Horisberger
Rahel Horisberger
CCClaudio Corda
Claudio Corda
NKNicolas Kleisner
Nicolas Kleisner
JKJulia Krasnoff
Julia Krasnoff
PHPhilipp Homan
Philipp Homan
Background and Hypothesis: Psychotic disorders are among the top causes of disability worldwide. Guidelines emphasize the need for psychotherapeutic approaches in the acute phase of this illness. Motivational interviewing (MI) is highly suitable for establishing a therapeutic alliance wherein the patient’s intrinsic motivation can be strengthened to adhere to therapy. This pilot study investigated the feasibility and impact of MI for patients with acute psychosis. Study Design: A feasibility study was conducted, comparing MI and supportive counseling. The sample included 20 inpatients, who all received 4 therapy sessions. In line with CONSORT guidelines for pilot and feasibility studies, we measured various feasibility outcomes. Clinical outcomes were assessed using linear regression models, with baseline values used as covariates. Study Results: The recruitment target (N = 24) was achieved at 83% in a reasonable timeframe (8 months), with a retention rate of 83% and a completion rate of 71%. The eligibility rate (82 %) was high, the consent rate (48%) was moderate, and both the dropout rate 17% and the missing data rate (0.3%) were low. Regarding the clinical outcomes, a group difference was found for the severity of psychotic symptoms, with an advantage for MI (b = −12.0, 95% CI: [−18.7, −5.2], P < 0.01), although the small sample size must be kept in mind. Conclusions: The study demonstrated the feasibility and acceptability of a clinical trial with MI for patients with psychosis in an inpatient setting. MI could offer benefits, particularly in terms of reducing psychotic symptoms.

14 July 2024 in medRxiv
Verified
Preprint
Open access
PDF file
Pierfrancesco SartiPierfrancesco Sarti
Pierfrancesco Sarti
WSWerner Surbeck
Werner Surbeck
GCGiacomo Cecere
Giacomo Cecere
NDNoemi Dannecker
Noemi Dannecker
RHRahel Horisberger
Rahel Horisberger
PHPhilipp Homan
Philipp Homan
Background Schizophrenia spectrum disorders and schizotypy share traits across positive, negative, and disorganized domains. Instruments like MSS and O-LIFE provide insights into these dimensions. Despite challenges posed by cultural variations and measurement methodologies, these instruments offer nuanced perspectives on the spectrum of schizotypy, spanning from its expression as a personality trait to its potential implications in clinical settings. Methods Through an Exploratory Graph Analysis (EGA) applied to a sample of 1059 healthy subjects, we compare the resulting networks with the original factorial structure of the two questionnaires and explore how each one conceptualizes schizotypy. Comparing both models quantitatively and qualitatively these models, we seek to elucidate the unique insights provided by each instrument regarding the spectrum of schizotypy as a personality trait. Results EGA analyses unveiled a three-dimensional structure plus an additional one consisting of items related to the concept of “Disconnection”. Confirmatory factor analysis showed this four-dimensional model outperformed others. High reliability and strong factor saturation were observed for all four factors. O-LIFE’s EGA revealed a complex structure, refined to four factors removing items with low fitting indices from the scale. Confirmatory analysis validated a final model with robust reliability and well-defined factor structures across the new “Cognitive and Behavioural Disorganization”, “Introversion”, “Unusual Experiences”, and “Environmental Pressure” factors. Conclusions This study improves the understanding of schizotypy by proposing new MSS and O-LIFE factor structures via EGA. Both scales uniquely contribute to schizotypy assessment in healthy populations, warranting further research to validate and refine these new domains across diverse populations.

7 November 2023 in PsyArXiv
Verified
Preprint
Open access
RHRahel Horisberger
Rahel Horisberger
SKStefan Kaiser
Stefan Kaiser
BKBirgit Kleim
Birgit Kleim
PHPhilipp Homan
Philipp Homan
Background: The development of new effective treatments for negative symptoms is urgently needed. Therefore, specific underlying psychological mechanisms need to be identified and addressed. One of these mechanisms could be so-called motives, which are a central element in the process of goal-directed behavior and influence whether needs are met or not. In the context of impaired motivational processing in psychosis patients, social motives appear to be associated with apathy, the motivational dimension of negative symptoms.Methods: In the present study of 42 inpatients with a diagnosis of psychosis, we examined in detail the differences in implicitly and explicitly reported motives in relation to motivational negative symptoms measured with the Brief Negative Symptoms Scale (BNSS) and with a self-rating scale (SNS). Implicit motives are described as largely unconscious and seem to determine how situations are perceived and which aspects attract attention. In contrast, explicit motives have the function of representing conscious goals and are closely related to one’s self-concept (Rawolle et al., 2013).Results: The results showed that especially the achievement motive is related to motivational negative symptoms: Pearson correlation between apathy and the explicit achievement motive was significant (r = -.458, p = .003), as well as between apathy and the implicit variant (r = -.509, p = .001).When taking the achievement motives into a multiple regression analysis to predict the severity of motivational negative symptoms, a significant regression equation was found (F(2, 38) = 10.541, p < .001), with a R2 of .357. Patient’s apathy scores decreased 0.40 points for each explicit-achievement score, and 0.36 points for each implicit-achievement score, what means that both, explicit and implicit achievement-scores are significant predictors of apathy. The effect size f2 was 0.146 and f = .382 (medium to strong). No relations were found for the affiliation- and the power motive, and as already shown in our previous work, no correlations were found between all motives and “diminished expression”, the non-motivational factor of negative symptoms. Self-reported motivational negative symptoms were found to be correlated with the explicit achievement motive (r = - .338, p = .045), but not with the implicit one. This probably fits with the fact that explicit motives are closely related to a person's self-image.Conclusion: Beside some limitations, the results of the present study represent an initial, potentially important approach for future investigation and treatment of negative symptoms in psychosis patients, as well as in other diagnostic groups with negative symptoms. It is possible that motives form a target for psychotherapeutic interventions. To what extent or in which way this could proceed forms the central question for our future research.

12 March 2024 in PsyArXiv
Verified
Preprint
Open access
JPJanani Panchalingam
Janani Panchalingam
RHRahel Horisberger
Rahel Horisberger
CCClaudio Corda
Claudio Corda
NKNicolas Kleisner
Nicolas Kleisner
JKJulia Krasnoff
Julia Krasnoff
PHPhilipp Homan
Philipp Homan
Background and objective: Psychotic disorders are among the top causes of disability world-wide. Guidelines emphasizes the need for research to tailor psychotherapeutic approaches to the acute phase of this illness. Motivational Interviewing (MI) is highly suitable for establishing a therapeutic alliance wherein the patient’s intrinsic motivation can be strengthened to adhere ther-apy and overcome ambivalence towards treatment. Therefore, this pilot study aimed to investigate the feasibility and impact of a brief intervention with MI for patients with psychosis in an acute psychiatric inpatient setting.Method: This pilot study was conducted as single-centered, randomized control trial (RCT), com-paring a brief intervention with MI and supportive conversations. The sample size included 20 newly admitted inpatients. In both conditions they received two sessions per week. In line with CONSORT guidelines for pilot and feasibility studies, we measured various feasibility outcomes. Additionally, we assessed various clinical outcomes using Analysis of Covariance (ANCOVA), with baseline values used as covariates.Results: The recruitment target (N = 24) was achieved at 83% in a reasonable timeframe (8 months), with a retention rate of 87% and completion rate at 71%. Eligibility rate (82 %) was high, while the consent rate (48%) was moderate and dropout rate 13% was low as well as the missing data (0.3%). With regard to the clinical outcomes, a group difference was found for the severity of psychotic symptoms, with an advantage for the MI intervention (b = -12.0, 95% CI: [-18.7, -5.2], p < 0.01), although this must be interpreted with caution in view of the small sample.Conclusion: The study demonstrated the feasibility and acceptability of conducting a clinical trial with MI for patients with psychosis in an acute inpatient psychiatric facility. MI has also demon-strated potential for greater benefits compared to supportive conversations, particularly in ad-dressing the severity of psychotic symptoms. Nevertheless, to obtain more definitive conclusions regarding efficacy, a larger-scale study is planned based on these promising results.

25 October 2023 in PsyArXiv
Verified
Preprint
Open access
RHRahel Horisberger
Rahel Horisberger
SKStefan Kaiser
Stefan Kaiser
MHMatthias Hartmann-Riemer
Matthias Hartmann-Riemer
Background: Motivational deficits are one of the main barriers in the recovery process of patients with schizophrenia. Psychological factors that might contribute to this loss need further investigation. Social motives could be a starting point, as they represent a central factor in the motivational process.Methods: We first investigated between-group differences in basic motivational systems for 32 healthy controls, 23 first-episode patients and 59 patients with schizophrenia. Secondly, we explored the relationship between negative symptoms and the single social motives in patients with schizophrenia.Results: Our findings are consistent with the hypothesis that specific motives are likely to be related to asociality, avolition and anhedonia, when patients suffer from psychotic disorders, and some motives can even predict the severity of motivational negative symptoms. Interestingly, social motives were not associated with diminished expression, suggesting that they specifically mediate the motivational aspects of negative symptoms.Further, as illness duration was significantly negatively correlated with some of the motive scores in patients with schizophrenia and because there were no differences in social motive scores between first-episode patients and healthy controls, we hypothesize that chronic illness may have a detrimental impact on motives and the motivational system. Discussion: Results from the present study warrant further research into motivational psychological factors in people with schizophrenia, which could have implications for improved psychotherapeutic interventions.